UniProt ID | LYPL1_HUMAN | |
---|---|---|
UniProt AC | Q5VWZ2 | |
Protein Name | Lysophospholipase-like protein 1 | |
Gene Name | LYPLAL1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 237 | |
Subcellular Localization |
Isoform 1: Cytoplasm, cytosol . Isoform 2: Cytoplasm, cytosol . |
|
Protein Description | Has depalmitoylating activity toward KCNMA1. Does not exhibit phospholipase nor triacylglycerol lipase activity, able to hydrolyze only short chain substrates due to its shallow active site.. | |
Protein Sequence | MAAASGSVLQRCIVSPAGRHSASLIFLHGSGDSGQGLRMWIKQVLNQDLTFQHIKIIYPTAPPRSYTPMKGGISNVWFDRFKITNDCPEHLESIDVMCQVLTDLIDEEVKSGIKKNRILIGGFSMGGCMAIHLAYRNHQDVAGVFALSSFLNKASAVYQALQKSNGVLPELFQCHGTADELVLHSWAEETNSMLKSLGVTTKFHSFPNVYHELSKTELDILKLWILTKLPGEMEKQK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAASGSVL ------CCCCCCCHH | 16.25 | 25944712 | |
7 | Phosphorylation | -MAAASGSVLQRCIV -CCCCCCCHHHHHHC | 19.70 | 28857561 | |
15 | Phosphorylation | VLQRCIVSPAGRHSA HHHHHHCCCCCCCEE | 6.79 | 21406692 | |
17 | Ubiquitination | QRCIVSPAGRHSASL HHHHCCCCCCCEEEE | 21.83 | 21890473 | |
21 | Phosphorylation | VSPAGRHSASLIFLH CCCCCCCEEEEEEEE | 20.42 | 27080861 | |
23 | Phosphorylation | PAGRHSASLIFLHGS CCCCCEEEEEEEECC | 25.64 | 27080861 | |
30 | Phosphorylation | SLIFLHGSGDSGQGL EEEEEECCCCCCHHH | 28.78 | 21406692 | |
32 | Ubiquitination | IFLHGSGDSGQGLRM EEEECCCCCCHHHHH | 51.82 | 21890473 | |
33 | Phosphorylation | FLHGSGDSGQGLRMW EEECCCCCCHHHHHH | 36.22 | 21406692 | |
41 | Ubiquitination | GQGLRMWIKQVLNQD CHHHHHHHHHHHCCC | 1.31 | 21890473 | |
55 (in isoform 1) | Ubiquitination | - | 22.41 | 21890473 | |
55 | Ubiquitination | DLTFQHIKIIYPTAP CCCEEEEEEEECCCC | 22.41 | 21890473 | |
55 (in isoform 2) | Ubiquitination | - | 22.41 | 21890473 | |
55 | Ubiquitination | DLTFQHIKIIYPTAP CCCEEEEEEEECCCC | 22.41 | 21890473 | |
66 | Phosphorylation | PTAPPRSYTPMKGGI CCCCCCCCCCCCCCC | 19.01 | - | |
70 | Ubiquitination | PRSYTPMKGGISNVW CCCCCCCCCCCCEEE | 56.01 | 21890473 | |
70 | Ubiquitination | PRSYTPMKGGISNVW CCCCCCCCCCCCEEE | 56.01 | 21890473 | |
70 (in isoform 1) | Ubiquitination | - | 56.01 | 21890473 | |
74 | Phosphorylation | TPMKGGISNVWFDRF CCCCCCCCEEEECEE | 28.71 | 28857561 | |
79 | Ubiquitination | GISNVWFDRFKITND CCCEEEECEEEEECC | 39.12 | 21890473 | |
124 | Phosphorylation | RILIGGFSMGGCMAI CEEEECCCHHHHHHH | 21.57 | - | |
151 | Ubiquitination | VFALSSFLNKASAVY HHHHHHHHHHHHHHH | 7.50 | 29967540 | |
164 | Ubiquitination | VYQALQKSNGVLPEL HHHHHHHCCCCCCHH | 26.34 | 29967540 | |
174 | Ubiquitination | VLPELFQCHGTADEL CCCHHHCCCCCHHHH | 2.21 | 21890473 | |
177 | Ubiquitination | ELFQCHGTADELVLH HHHCCCCCHHHHHHH | 13.79 | 21890473 | |
186 | Ubiquitination | DELVLHSWAEETNSM HHHHHHHHHHHHHHH | 9.28 | 29967540 | |
190 | Ubiquitination | LHSWAEETNSMLKSL HHHHHHHHHHHHHHC | 24.89 | 21890473 | |
199 | Ubiquitination | SMLKSLGVTTKFHSF HHHHHCCCCCCCCCC | 8.13 | 21890473 | |
202 | Ubiquitination | KSLGVTTKFHSFPNV HHCCCCCCCCCCCCH | 31.54 | 29967540 | |
202 | Acetylation | KSLGVTTKFHSFPNV HHCCCCCCCCCCCCH | 31.54 | 25953088 | |
202 | Malonylation | KSLGVTTKFHSFPNV HHCCCCCCCCCCCCH | 31.54 | 30639696 | |
212 (in isoform 2) | Ubiquitination | - | 36.73 | 21890473 | |
212 | Ubiquitination | SFPNVYHELSKTELD CCCCHHHHCCHHHHH | 36.73 | 21890473 | |
214 | Phosphorylation | PNVYHELSKTELDIL CCHHHHCCHHHHHHH | 34.25 | 29083192 | |
221 | Ubiquitination | SKTELDILKLWILTK CHHHHHHHHHHHHHC | 3.58 | 21890473 | |
228 | Ubiquitination | LKLWILTKLPGEMEK HHHHHHHCCCCHHHH | 49.60 | 21890473 | |
228 (in isoform 1) | Ubiquitination | - | 49.60 | 21890473 | |
228 | Ubiquitination | LKLWILTKLPGEMEK HHHHHHHCCCCHHHH | 49.60 | 21890473 | |
235 | Ubiquitination | KLPGEMEKQK----- CCCCHHHHCC----- | 63.18 | - | |
237 | Ubiquitination | PGEMEKQK------- CCHHHHCC------- | 73.67 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LYPL1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LYPL1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LYPL1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of LYPL1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. |